Phase III randomized study of postradiotherapy chemotherapy with α-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) Versus PCV for glioblastoma multiforme

Victor A. Levin, Joon H. Uhm, Kurt A. Jaeckle, Ali Choucair, Patrick J. Flynn, W. K.Alfred Yung, Michael D. Prados, Janet M. Bruner, Susan M. Chang, Athanassios P. Kyritsis, Mary Jo Gleason, Kenneth R. Hess

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III randomized study of postradiotherapy chemotherapy with α-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) Versus PCV for glioblastoma multiforme'. Together they form a unique fingerprint.

Medicine & Life Sciences